2020 CAGPO CONFERENCE AGENDA

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 14.00  Mainpro+ credits.

Times are EDT.

To view the authorized presentations with your password, please click here have access to the presentation links.

Friday, September 25, 2020  
8:50 – 9:00 am Welcome – from CAGPO – Dr. Tunji Fatoye
 
9:00 – 9:45 am “Managing Cancer and Living Meaningfully (CALM): A Brief Psychotherapy for Patients Living with Advanced Disease”
Dr. Sarah Hales & Dr. Lucie Blouin
 
9:45 – 10:15 am Chemo Brain: Causes and Cures
Dr. Lori Bernstein
 
10:15 – 10:25 am Break
 
10:25 – 11:10 am Treatment of CNS Primaries: Standard Management and Emerging Therapies
Dr. Hal Hirte
 
11:10 – 11:55 am Radiation Toxicity Management
Abhirami Hallock
 
11:55 – 12:15 pm Lunch / Exhibits
 
12:15 – 1:15 pm Symposium – A History of Breast Cancer Treatment
Dr. Maureen Trudeau
 
1:15 – 2:00 pm Indigenous Care Update
Dr. Amy Montour
 
2:00 – 2:10 pm Break / Exhibits
 
2:10 - 2:55 pm An Overview of Treatment of Sarcoma for the GPO
Dr. Kevin Zbuk
 
2:55 – 3:55 pm ASCO Update
Dr. Hamid Mithoowani
 
3:55 - 4:00 pm Break / Exhibits
   
4:00 - 4:45 pm IVR and Liver Tumors / Mets – RFA/TACE
Dr. Khalid Hussain
 

6:30 – 8:00 pm

CAGPO Business Meeting (via Zoom)

Saturday, September 26, 2020  
8:45 – 9:45 am Symposium – Toxicity Management for IO Drugs
Dr. Parneet Cheema
 
9:45 – 10:30 am Treatment of Triple Negative Breast Cancer
Dr. Hamid Mithoowani
 
10:30 – 10:40 am Break 
 
10:40 – 11:25 am Treatment of Small Cell Lung Cancer in 2020
Dr. Peter Ellis
 
11:25 am – 12:25 pm Clinical Trials and NGS
Dr. Ros Juergens
 
12:25 – 1:15 pm Lunch
 
1:15 – 2:00 pm Thyroid Nodules Management
Dr. Meera Luthra
 
2:00 – 2:45 pm Metastatic Prostate Cancer Treatment
Dr. Aly-Khan Lalani
 
2:45 - 3:30 pm Neuroendocrine Overview
Dr. Radhika Yelamanchili
 
3:30 – 3:40 pm Break / Exhibits
 
3:40 – 4:25 pm Treatment of Seizures 
Dr. Joseph Perumpillichira
 
4:25 – 5:20 pm Rectal Cancer
Dr. Ken Leung